ACE and Hyponatremia: The risk for hyponatremia increases when SSRI and SNRI are used in combination with angiotensin-converting enzyme (ACE) inhibitors, thiazide and thiazide-like diuretics, and proton pump inhibitors [19, 73, 74], inducing additive pharmacodynamic effects [19, 75].